TY - JOUR
T1 - Effects of the novel D1 dopamine receptor agonist ABT-431 on cocaine self-administration and reinstatement
AU - Self, David W.
AU - Karanian, David A.
AU - Spencer, Jennifer J.
PY - 2000
Y1 - 2000
N2 - Selective D1 dopamine agonists represent a potential pharmacotherapy for the treatment of cocaine addiction. Here we report that systemic injections of the novel D1 agonist ABT-431 lack the ability to induce cocaine-seeking behavior, and completely attenuate the ability of cocaine to induce this behavior in rats tested in a reinstatement paradigm. Similar doses suppress the initiation of cocaine self-administration, and produce an extinction-like response pattern in animals that subsequently initiate self-administration, without altering responding maintained by food pellets. There was no tolerance to this effect over 4 days of testing. The results suggest that ABT-431 attenuates the motivation to seek cocaine, and masks the reinforcing effects of cocaine during self-administration. The profile of ABT-431 is similar to the behavioral effects of other structurally distinct D1 agonists, and is consistent with the desired profile of a 'methadone-like' compound for cocaine addiction.
AB - Selective D1 dopamine agonists represent a potential pharmacotherapy for the treatment of cocaine addiction. Here we report that systemic injections of the novel D1 agonist ABT-431 lack the ability to induce cocaine-seeking behavior, and completely attenuate the ability of cocaine to induce this behavior in rats tested in a reinstatement paradigm. Similar doses suppress the initiation of cocaine self-administration, and produce an extinction-like response pattern in animals that subsequently initiate self-administration, without altering responding maintained by food pellets. There was no tolerance to this effect over 4 days of testing. The results suggest that ABT-431 attenuates the motivation to seek cocaine, and masks the reinforcing effects of cocaine during self-administration. The profile of ABT-431 is similar to the behavioral effects of other structurally distinct D1 agonists, and is consistent with the desired profile of a 'methadone-like' compound for cocaine addiction.
UR - http://www.scopus.com/inward/record.url?scp=0033623870&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0033623870&partnerID=8YFLogxK
U2 - 10.1111/j.1749-6632.2000.tb06679.x
DO - 10.1111/j.1749-6632.2000.tb06679.x
M3 - Article
C2 - 10911927
AN - SCOPUS:0033623870
SN - 0077-8923
VL - 909
SP - 133
EP - 144
JO - Annals of the New York Academy of Sciences
JF - Annals of the New York Academy of Sciences
ER -